Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €7.63 | €21.44 | 180.827% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.56 | - | - |
| Bluebird Bio Inc. | 7 | 6 | 3 | 0 | €0.51 | €5.47 | 976.366% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| T2 Biosystems Inc. | 0 | 4 | 0 | 0 | €0.16 | - | - |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.22 | €7.31 | 127.384% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.58 | - | - |
| Viking Therapeutics Inc | 5 | 1 | 0 | 1 | €58.02 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.85 | €2.00 | 135.183% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.00 | - | - |
| Natural Alternat. | 19 | 1 | 0 | 0 | €4.74 | - | - |
| Bristol-Myers Squibb | 7 | 3 | 0 | 1 | €45.21 | €67.64 | 49.627% |
| InVivo Therapeutics Holdings | 0 | 13 | 0 | 0 | €0.31 | - | - |
| Pacific Biosciences of California Inc. | 10 | 4 | 1 | 0 | €1.24 | €9.20 | 639.228% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Edap Tms S.A. ADR | 5 | 1 | 1 | 0 | €2.80 | €17.46 | 523.607% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €5.29 | €11.00 | 108.018% |
| Nevro Corp. | 1 | 4 | 0 | 1 | €5.60 | €13.77 | 145.909% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 87.849% |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.11 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.06 | €50.00 | 4603.669% |
| Integra LifeSciences Holdings Corp | 3 | 6 | 0 | 2 | €18.60 | €31.62 | 69.975% |